Industrial Health and Safety: Females

(asked on 22nd February 2022) - View Source

Question to the Department for Work and Pensions:

To ask the Secretary of State for Work and Pensions, what work is being done by the Health and Safety Executive towards improving protections for women workers against endocrine-disrupting chemicals; and what analysis has been undertaken on the outcomes of women workers' exposure to such chemicals.


Answered by
Chloe Smith Portrait
Chloe Smith
This question was answered on 28th February 2022

Specific control measures exist to minimise exposure to chemicals with endocrine disrupting properties through the Health and Safety Executive’s (HSE) regulatory work on plant protection products (pesticides) and biocides, and through its regulatory regimes (Classification, Labelling and Packaging (CLP) and Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)). These measures apply to all workers and they aim to reduce use and exposure to such chemicals and stimulate replacement with safer alternatives. This framework does not specifically target women’s exposure to Endocrine Disrupting Chemicals (EDCs).

CLP classifies chemicals, including those with endocrine disrupting properties, for the intrinsic hazards they possess, and this will filter through to labels, safety data sheets and other controls in order to reduce use and exposure to such chemicals and recommend safer alternatives.

Regulation 16 of The Management of Health and Safety at Work Regulations 1999 (MHSWR) requires the risk assessment to include any risks to females of childbearing age who could become pregnant, and any risks to new and expectant mothers. These risks can be from any process, working condition or work involving physical, biological or chemical agents.

No specific analysis has been undertaken by HSE on the outcomes of women workers as a result of exposure to endocrine disrupting chemicals.

Reticulating Splines